FDA Approves Lab Test to Help Detect Myeloma
The U.S. Food and Drug Administration (FDA) recently approved a lab test to aid in the detection and diagnosis of myeloma and a range of…
News
Bristol-Myers Squibb Issues Four-year Follow-up Findings for Empliciti Triple Combo Therapy
Treatment with Empliciti (elotuzumab) plus Revlimid (lenalidomide) and dexamethasone (ELd) in patients with relapsed/refractory multiple myeloma (RRMM) continued to show effectiveness in the Phase 3…
Potential Use of Ninlaro as Maintenance Therapy in Multiple Myeloma Shown in Phase 1/2 Trials
Patients with newly diagnosed multiple myeloma benefit significantly from a combination of Ninlaro (ixazomib) plus Revlimid (lenalidomide) and dexamethasone, followed by Ninlaro maintenance therapy, according…
76-year-old Don Wright Has New Goal After Completing 100 Marathons with Myeloma
Doctors told Don Wright he had five years to live when he was diagnosed with multiple myeloma in 2003. Instead of resigning himself to this…
FDA Will Review Amgen’s Request to Expand Use of Xgeva for Multiple Myeloma
The U.S. Food and Drug Administration (FDA) has accepted a supplemental biologics license application (sBLA) seeking to expand the currently approved indication of Xgeva…
FDA Approves Darzalex Combo Therapy for Previously Treated Multiple Myeloma Patients
The U.S. Federal Drug Administration has approved a combination of the immunotherapies Darzalex (daratumumab), Pomalyst (pomalidomide) and dexamethasone as a multiple myeloma treatment, according to…
Dragonfly Therapeutics and Celgene Partnering on Blood-Cancer Therapies
Dragonfly Therapeutics and Celgene have teamed up to develop therapies for multiple myeloma and other blood cancers. The partners will use Dragonfly’s TriNKET immunotherapy…
First Patient Dosed in Phase 3 BOSTON Trial Evaluating Selinexor for Multiple Myeloma
Massachusetts–based Karyopharm Therapeutics announced that the first patient was dosed in its pivotal BOSTON Phase 3 clinical trial…
BMT Program at MedStar Georgetown Completes 100th Blood Stem Cell Transplant
John Theurer Cancer Center and MedStar Georgetown University Hospital have announced the completion of the 100th blood stem cell transplant since its joint…
Myeloma Patient Enrollment in 2 Keytruda Trials Suspended After Unexplained Deaths
Merck has suspended patient enrollment in two Phase 3 clinical trials, KEYNOTE-183 and KEYNOTE-185, testing Keytruda (pembrolizumab) in combination with other therapies in patients…
